Quarterly report pursuant to Section 13 or 15(d)

Net income (loss) Per Share Attributable to Common Stockholders - Antidilutive Securities (Details)

v3.23.3
Net income (loss) Per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 19,828,854 7,510,975 19,828,854 11,574,074
Redeemable convertible preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 4,739,336 0 4,739,336 0
Common stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 1,926,511 1,619,811 1,926,511 4,833,767
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 5,161,753 60,728 5,161,753 810,582
Warrant | Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 2,598,554 80,740 2,598,554 180,029
Warrant | Private and Public Placement Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 2,800,146 2,950,000 2,800,146 2,950,000
Earn-Out Shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 2,602,554 2,799,696 2,602,554 2,799,696